Abstract

Nitric oxide and secondary oxides of nitrogen react with unsaturated fatty acids such as linoleic acid to yield oxidized and nitrated products. Fatty acid nitroalkene derivatives, (e.g. nitrolinoleate [LNO2]) are produced by oxidative inflammatory reactions, detected clinically, display potent electrophilic reactivity and induce post-translational protein modifications that mediate adaptive inflammatory signaling responses. LNO2 signaling was examined in lung epithelial cells because the alveolar compartment is a rich site for the transduction of redox and inflammatory reactions. LNO2 did not directly induce Ca2+ influx in cultured lung epithelial cells, but inhibited bradykinin-induced Ca2+ influx in a cGMP-independent manner. In contrast, LNO2 activated MAP kinase (Erk1/2) by a mechanism independent of bradykinin. It was hypothesized that these unique responses were transduced by activation of different protein kinase C isotypes, supported by the observation that LNO2-mediated inhibition of Ca2+ influx was blocked by the non-selective PKC inhibitors chelerythine chloride and calphostin C, but not by the calcium dependent “classic” PKC inhibitor Gö6976. Western blot analysis showed that atypical PKCζ was activated by LNO2 stimulation, with PKCζ and Erk activation also demonstrated in primary culture of human lung type II cells. Addition of pseudotypical PKCζ substrate peptide reversed LNO2-mediated induction of Ca2+ influx and MAP kinase activation. Finally, the electrophilic nature of LNO2 resulted in a novel mode of PKCζ activation, covalent adduction of the enzyme. In summary, LNO2 mediated signaling in lung type II epithelial cells occurs via a unique pathway involving PKCζ.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call